We are live on ! Find out more
CBMG

Cellular Biomedicine Group, Inc.
CBMG

Delisted

CBMG was delisted on the 19th of February, 2021.

Back to rankings

0 hedge funds and large institutions have $0 invested in Cellular Biomedicine Group, Inc. in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 66 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 67 → 0 (-67)

100% less capital invested

Capital invested by funds: $80M → $0 (-$80M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 66

Holders
–
Holders Change
-67
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
66
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$16.1M
2
CS
Candriam SCA
Luxembourg
-$4.33M
3
HA
HHLR Advisors
Cayman Islands
-$4.32M
4
GCL
Glazer Capital LLC
New York
-$4.27M
5
State Street
State Street
Massachusetts
-$4.17M
Name Holding Trade Value Shares
Change 		Change in
Stake
WAM
26
Wolverine Asset Management
Illinois
– -$602K -32,787 Closed
FTCM
27
First Trust Capital Management
Illinois
– -$601K -32,688 Closed
Charles Schwab
28
Charles Schwab
California
– -$527K -28,661 Closed
California Public Employees Retirement System
29
California Public Employees Retirement System
California
– -$471K -25,600 Closed
Wells Fargo
30
Wells Fargo
California
– -$461K -25,093 Closed
GC
31
Guggenheim Capital
Illinois
– -$402K -21,895 Closed
Marshall Wace
32
Marshall Wace
United Kingdom
– -$392K -21,315 Closed
UBS Group
33
UBS Group
Switzerland
– -$392K -21,311 Closed
Dimensional Fund Advisors
34
Dimensional Fund Advisors
Texas
– -$390K -21,197 Closed
California State Teachers Retirement System (CalSTRS)
35
California State Teachers Retirement System (CalSTRS)
California
– -$346K -18,844 Closed
DTL
36
Dynamic Technology Lab
Singapore
– -$330K -17,929 Closed
YCM
37
Yakira Capital Management
Connecticut
– -$323K -17,588 Closed
State of Wisconsin Investment Board
38
State of Wisconsin Investment Board
Wisconsin
– -$302K -16,500 Closed
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
– -$298K -16,228 Closed
Capstone Investment Advisors
40
Capstone Investment Advisors
New York
– -$249K -13,564 Closed
E
41
Ergoteles
New York
– -$244K -13,273 Closed
AllianceBernstein
42
AllianceBernstein
Tennessee
– -$237K -12,900 Closed
New York State Common Retirement Fund
43
New York State Common Retirement Fund
New York
– -$237K -12,900 Closed
VIA
44
Vident Investment Advisory
Georgia
– -$229K -12,457 Closed
Goldman Sachs
45
Goldman Sachs
New York
– -$225K -12,249 Closed
Nisa Investment Advisors
46
Nisa Investment Advisors
Missouri
– -$224K -12,175 Closed
Deutsche Bank
47
Deutsche Bank
Germany
– -$165K -8,985 Closed
FFH
48
Fairfax Financial Holdings
Ontario, Canada
– -$158K -8,600 Closed
Bank of America
49
Bank of America
North Carolina
– -$146K -7,956 Closed
AIG
50
American International Group
New York
– -$132 -7,161 Closed
1
2
3

CBMG Hedge Fund Activity: Q1 2021 in Review

0 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Cellular Biomedicine Group, Inc. (CBMG) for Q1 2021, worth a combined $0 — down 100% from $80M a quarter earlier.

Sellers outnumbered buyers: 66 funds closed out of CBMG and 0 opened new positions — a net loss of 66 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $16.1M sold.

  • 0 institutional investors held Cellular Biomedicine Group, Inc. (CBMG) as of Q1 2021, down from 67 in Q4 2020.
  • Funds reported $0 of Cellular Biomedicine Group, Inc. stock for Q1 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Cellular Biomedicine Group, Inc. positions in Q1 2021 and 66 closed out, a net change of -66 holders.
  • The largest Cellular Biomedicine Group, Inc. seller in Q1 2021 was BlackRock, an estimated $16.1M sold.

Based on aggregated 13F filings for Q1 2021.